Under development:
Drug companies are on the hunt for new ways to block inflammation in psoriatic disease. Some ideas involve combining biologics or targeting more than one inflammatory pathway at once. For example, a drug in development, bimekizumab, targets two inflammatory proteins, IL-17A and IL-17F. In studies, it helped some people's symptoms improve by as much as 90%.
thanks so much for sharing this. Do you happen to have a source where we could read more information about it? I know people here appreciate hearing about any new and promising treatment options. -- Warmly, Christine (Team Member) Dewi here:
Hopefully this hyper-link is stable within this particular forum (not all the forums I participate in are) so you can activate it.
If not I'll DM you - if that's possible...
https://www.webmd.com/skin-problems-and-treatments/psoriasis/psoriatic-21/innovations-psoriatic-disease-autoimmunethanks for sharing it. We can always copy and paste it too. I appreciate you sharing it! -- Warmly, Christine (Team Member)
